Morbidity of acute pancreatitis: the effect of aprotinin and glucagon.
In a double-blind, randomised trial, neither aprotinin nor glucagon given in relatively high doses for five days influenced the rate of recovery or incidence of complications in 257 patients with acute pancreatitis.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D007611:Aprotinin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005934:Glucagon / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D010195:Pancreatitis / Q000150:complications / Q000188:drug therapy*; D011897:Random Allocation
D005934:Glucagon; D007611:Aprotinin